MENU
+Compare
RXRX
Stock ticker: NASDAQ
AS OF
Jun 24, 12:16 PM (EDT)
Price
$5.20
Change
+$0.37 (+7.66%)
Capitalization
1.96B

RXRX Recursion Pharmaceuticals Forecast, Technical & Fundamental Analysis

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RXRX with price predictions
Jun 23, 2025

RXRX in upward trend: 10-day moving average moved above 50-day moving average on June 12, 2025

The 10-day moving average for RXRX crossed bullishly above the 50-day moving average on June 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for RXRX just turned positive on May 27, 2025. Looking at past instances where RXRX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RXRX advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RXRX as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RXRX moved below its 50-day moving average on June 23, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RXRX broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RXRX entered a downward trend on June 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.102) is normal, around the industry mean (16.460). P/E Ratio (0.000) is within average values for comparable stocks, (58.911). RXRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.291). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (25.510) is also within normal values, averaging (252.526).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RXRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RXRX is expected to report earnings to fall 31.60% to -34 cents per share on August 12

Recursion Pharmaceuticals RXRX Stock Earnings Reports
Q2'25
Est.
$-0.34
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 05 showed earnings per share of -50 cents, missing the estimate of -49 cents. With 5.51M shares outstanding, the current market capitalization sits at 1.96B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDTCX30.79N/A
N/A
Fidelity Advisor Diversified Stock C
RSNYX37.85N/A
N/A
Victory Global Energy Transition Y
SCWCX56.28N/A
N/A
American Funds SMALLCAP World C
ACSMX10.74N/A
N/A
Advisors Capital Small/Mid Cap
MXEVX11.58N/A
N/A
Empower Core Strategies Intl Eq Inv

RXRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.78%
CRSP - RXRX
72%
Closely correlated
+2.94%
BEAM - RXRX
63%
Loosely correlated
-0.30%
ABSI - RXRX
61%
Loosely correlated
-1.08%
ABCL - RXRX
58%
Loosely correlated
-2.35%
PRME - RXRX
56%
Loosely correlated
+4.35%
More

Groups containing RXRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.78%
RXRX
(2 stocks)
81%
Closely correlated
+5.39%